Comparisons of verapamil administration twice and three times daily in hypertension. 1988

P I Salmela, and A Gordin, and H Salo, and P Ottoila, and A J Jounela
Department of Medicine, University Central Hospital, Oulu, Finland.

The antihypertensive effect of verapamil administered either two or three times daily was compared in a double blind, cross over study in 15 patients with mild to moderate essential hypertension. During the dose titration period with t.i.d. administration, normotension was obtained with daily doses of 240 mg in 7 patients, 360 mg in 7 patients and with 480 mg in one patient. Systolic and diastolic blood pressures (BP) in the supine (13/14 mmHg) and standing (14/14 mmHg) positions were significantly (p less than 0.001) reduced during the dose titration period. There was no statistically significant difference in the BP values between the twice and three times a day regimens. Five to 7-fold individual variations in the serum verapamil concentrations between individuals were observed. No significant correlations were found between serum drug concentrations and the change in mean arterial BP. There was no significant difference in the incidence of side effects between the two treatment regimens. Our results suggest that verapamil administered twice daily is effective in mild to moderate hypertension.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P I Salmela, and A Gordin, and H Salo, and P Ottoila, and A J Jounela
March 1986, Archives of internal medicine,
P I Salmela, and A Gordin, and H Salo, and P Ottoila, and A J Jounela
October 1996, Pediatrics,
P I Salmela, and A Gordin, and H Salo, and P Ottoila, and A J Jounela
February 1986, The American journal of cardiology,
P I Salmela, and A Gordin, and H Salo, and P Ottoila, and A J Jounela
January 1981, Journal of clinical pharmacology,
P I Salmela, and A Gordin, and H Salo, and P Ottoila, and A J Jounela
January 1983, Hypertension (Dallas, Tex. : 1979),
P I Salmela, and A Gordin, and H Salo, and P Ottoila, and A J Jounela
June 1982, British journal of clinical pharmacology,
P I Salmela, and A Gordin, and H Salo, and P Ottoila, and A J Jounela
February 1980, British journal of clinical pharmacology,
P I Salmela, and A Gordin, and H Salo, and P Ottoila, and A J Jounela
September 2000, British journal of clinical pharmacology,
P I Salmela, and A Gordin, and H Salo, and P Ottoila, and A J Jounela
July 2000, AIDS (London, England),
P I Salmela, and A Gordin, and H Salo, and P Ottoila, and A J Jounela
May 2009, Acta oto-laryngologica,
Copied contents to your clipboard!